Save Mifepristone: People’s Brief
On Friday, April 7, 2023, Texas-based U.S. District Court Judge Matthew Kacsmaryk delivered his decision in Alliance for Hippocratic Medicine et al v. U.S. Food and Drug Administration et al, ruling that mifepristone should be pulled from the market.
On Wednesday, April 12, 2023, a three-judge panel for the Fifth Circuit Court of Appeals partly overruled Kacsmaryk’s decision, stating that the FDA’s approval of mifepristone remains valid while also ruling to reinstate medically unnecessary restrictions to accessing the medication.
This decision could result in a devastating, nationwide ban on mifepristone — even in states where abortion is legally protected — and compromise access to medication abortion across the country.
USOW and our partners across the country are mobilizing behind a united message to our judiciary: reverse this harmful decision, respect science, and uphold the law.